DOCSLIB.ORG

Combined Low Calcium and Lack Magnesium Is a Risk Factor for Motor Deficit in Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Combined Low Calcium and Lack Magnesium Is a Risk Factor for Motor Deficit in Mice Biosci. Biotechnol. Biochem., 77 (2), 266–270, 2013 Combined Low Calcium and Lack Magnesium Is a Risk Factor for Motor Deficit in Mice y Ryoo TANIGUCHI,1 Osamu NAKAGAWASAI,1; Koichi TAN-NO,1 Fumihiro YAMADERA,1 Wataru NEMOTO,1 Shoko SATO,1;2 Fukie YAOITA,1 and Takeshi TADANO1;3 1Department of Pharmacology, Tohoku Pharmaceutical University, Sendai 981-8558, Japan 2Department of Pharmaceutical Sciences, Tohoku Pharmaceutical University, Sendai 981-8558, Japan 3Laboratory of Environmental and Health Sciences, College of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan Received August 28, 2012; Accepted October 18, 2012; Online Publication, February 7, 2013 [doi:10.1271/bbb.120671] The populations of the Kii Peninsula in Japan and of and abnormal deposits have been observed in the brains Guam present high incidences of amyotrophic lateral of patients with PD.1,2) Of particular interest is the sclerosis and Parkinsonism-dementia complex. It is higher incidence of PD and amyotrophic lateral selerosis thought that low levels of calcium (Ca) and magnesium (ALS) among the Auyu and Jakai people on the southern (Mg) in the drinking water are involved in the patho- coastal plain of West New Guinea and the Japanese genesis of these diseases. The present study aimed to test residents of the Kii Peninsula which is attributed to a the hypothesis that catalepsy, behavioral immobility and marked deficiency of Ca and Mg in the soil and water of a Parkinsonian symptom results from functionally these regions.3) Likewise, a survey of Guam also impaired dopaminergic neurons in mice fed low suggested that low Ca and Mg (LCa/Mg) and high amounts of Ca and Mg (LCa/Mg). A group of mice aluminum (Al) and manganese (Mn) in river, soil, and fed a LCa/Mg diet for 6 weeks was compared to a drinking water might be responsible for the higher control group on a standard diet. Cataleptic symptoms incidence of PD in that region.4) Furthermore, a LCa/ such as akinesia and rigidity were measured by the bar Mg diet has been found to accelerate the deposition of test. The anti-parkinsonian drugs dopamine (DA) pre- Mn and Al in the brain.5) Although numerous studies cursor L-3,4-dihydroxy phenylamine (L-DOPA), the have investigated the role of Mg in the etiology of 3,6) selective DA receptor D2 agonist bromocriptine, and clinical and experimental PD, reports on animal the DA releaser amantadine were tested for their effects behavior after LCa/Mg feeding are scarce. The present on induced catalepsy. The mice developed catalepsy study aimed to test the hypothesis that catalepsy can after 3 weeks on the LCa/Mg diet. LCa/Mg diet- result from damage to DA-ergic neurons in LCa/Mg fed induced catalepsy was improved by the administration mice. Accordingly, we examined the effects of DA-ergic of L-DOPA (50–200 mg/kg i.p.) in combination with drugs on the catalepsy induced by LCa/Mg in mice and benserazide (25 mg/kg i.p.), or of bromocriptine (0.25– also intensity tyrosine hydroxylase (TH) immunofluo- 4 mg/kg i.p.) or of amantadine (5–20 mg/kg i.p.). rescence in the SN. Immunohistochemical staining revealed that the inten- sity of tyrosine hydroxylase fluorescence was signifi- Materials and Methods cantly decreased in the substantia nigra at the 6th week of LCa/Mg feeding in comparison with pair-fed con- Animals. Male ddY mice (Japan SLC, Hamamatsu, Japan) weighing trols. These results suggest that catalepsy in LCa/Mg 10 g (post-natal days 20–21) at the beginning of the experiment, were mice results from hypofunction of the dopaminergic used. The animals were housed in plastic cages (31 cm  21 cm  neurons. Moreover, our results support the hypothesis 13 cm) under conditions of constant temperature (23 Æ 1 C), humidity that LCa/Mg intake is one etiological factor in neuro- (55 Æ 5%), and light-dark cycle (light from 9 to 21 h; dark from 21 to degenerative disorders, including Parkinson’s disease. 9 h). The mice had free access to food and water throughout the experimental period. They were divided into three dietary groups for 6 weeks: (i) a low Ca and Mg deficient diet (LCa/Mg) group, (ii) a Key words: calcium; catalepsy; dopamine; magnesium pair-fed (PF) group for LCa/Mg group, and (iii) a control group. The control group had access to a normal diet ad libitum (standard mineral Parkinson’s disease (PD) is characterized by a loss of diet: CLEA Japan, Tokyo). The PF group was also given the standard dopaminergic neurons in the substantia nigra (SN) diet, the amount of food was matched to that of the corresponding accompanied by a reduction in striatal dopamine (DA). deficient diet group (i). The PF groups were included to control for the The etiology of the disease remains unclear, but it is now effects of anorexia. The deficient diet group (i) was given distilled and deionized milli-Q water to drink. All the diet ingredients (CLEA widely accepted that many factors are involved in the Japan) are listed in Table 1. All experiments were performed following development of this neuropathology. Certain metals the Guide for the Care and Use of Laboratory Animals of Tohoku have been suggested to play roles, as imbalanced levels Pharmaceutical University. y To whom correspondence should be addressed. Tel/Fax: +81-22-727-0123; E-mail: [email protected] Abbreviations: LCa/Mg, low Ca and Mg; DA, dopamine; L-DOPA, L-3,4-dihydroxy phenylamine; PD, Parkinson’s disease; SN, substantia nigra; ALS, amyotrophic lateral selerosis; Al, aluminum; Mn, manganese; TH, tyrosine hydroxylase; PF, pair-fed; i.p., intraperitoneally; ANOVA, analysis of variance; SEM, standard error of the mean; MPPþ, 1-methyl-4-phenylpyridinium; NMDA, N-methyl-D-aspartate Low Calcium and Magnesium as Risk Factor 267 Drugs. All drugs were purchased from Sigma Chemical (St. Louis, previous reports.7,8) The TH antibody (diluted 1:200) was applied to MO). Bromocriptine, L-DOPA, and benserazide were dissolved in each brain slice, which was then incubated at 4 C for 12 h. The 0.5% Tween80. Amantadine was dissolved in saline. Bromocriptine secondary antibody, FITC-labeled anti-rabbit IgG goat serum (diluted (0.25, 1, and 4 mg/kg), L-DOPA (50, 100, and 200 mg/kg) and 1:200), was allowed to react in the dark at room temperature for 3 h. amantadine (5, 10, and 20 mg/kg) were injected 30 min before the The stained sections were mounted in 10% glycerin-PBS and kept at catalepsy test. Benserazide (25 mg/kg) was injected 30 min before 4 C in a dark room until measurements were done. The distribution of L-DOPA. All drug injections were performed intraperitoneally (i.p.). TH was analyzed quantitatively using a modified brain mapping analyzer system (Yamato Scientific, Tokyo). The background value, Catalepsy test. The bar test was used to measure cataleptic including nonspecific fluorescence originating from glutaraldehyde, symptoms, including akinesia and rigidity. Catalepsy was evaluated was subtracted photometrically from the total fluorescence intensities by placing both forepaws of the mouse on a horizontal bar (diameter obtained for the region of interest. The resulting values were compared 0.2 cm) elevated 5 cm from the floor. The degree of catalepsy was to those of the standard, 1 mM quinine sulphate.7) assessed by measuring the time from placement of the forepaws to removal of one of them (descent latency), with a cut-off time of 180 s. Statistical analysis. Significance of differences was determined by The anti-Parkinsonian drugs bromocriptine (a DA receptor D2 Student’s t-test for two-group comparison. Analysis of variance agonist), L-DOPA (a precursor of DA), and amantadine (a DA (ANOVA) was used for multiple comparisons. Post hoc analysis was releaser) were tested at the 6th week in the cataleptic LCa/Mg mice. performed by Fisher’s PLSD test. The criterion of significance was set The duration of catalepsy was measured 0.5, 1, 2 and 24 h after i.p. at p < 0:05. All results were expressed as mean Æ standard error of the administration of a vehicle, bromocriptine (0.25–4 mg/kg) (Fig. 3), mean (SEM). benserazide (25 mg/kg) + L-DOPA (50–200 mg/kg) (Fig. 4), or amantadine (5–20 mg/kg) (Fig. 5). Results Immunohistochemical procedures. Behavioral testing was followed by immunohistochemical analysis of TH. The mice were anesthetized Growth curves and mortality rate with sodium pentobarbital (50 mg/kg i.p.; Dainippon, Osaka, Japan) The mice on the standard mineral and the exper- perfused through the heart with ice-cold phosphate-buffered saline imental diets were housed individually for food intake (PBS, pH 7.4), followed immediately by a fixative containing 4% assessment. As shown by the growth curves in Fig. 1, paraformaldehyde (Sigma) and 0.2% glutaraldehyde (Nacalai Tesque, despite the LCa/Mg diet, the average body weight at the Osaka, Japan) in PBS. The brains were then post-fixed with the same fixative solution at 4 C for 1 h, and placed in 10% sucrose solution at end of the first week had increased steadily to about 4 C for 12 h. The tissue was frozen on dry ice and sliced into 20-mm 14 g, similarly to what was observed for the mice in the sections on a cryostat (Leitz, Stuttgart, Germany). Two to four brain PF group. The LCa/Mg mice showed aphagia from the sections per animal containing the SN were used in analysis. The 2nd week onwards (Table 2). Accordingly, the weight of immunohistochemical staining procedure was performed following these mice started to plateau and to differ significantly from the PF group, which continued to increase (Fig.
Load more

Recommended publications
  • The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1
    The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1 Psychotic Disorders Slide 2 As with all the disorders, it is preferable to pick Archetype one “archetypal” disorder for the category of • Schizophrenia disorder, understand it well, and then know the others as they compare. For the psychotic disorders, the diagnosis we will concentrate on will be Schizophrenia. Slide 3 A good way to organize discussions of Phenomenology phenomenology is by using the same structure • The mental status exam as the mental status examination. – Appearance –Mood – Thought – Cognition – Judgment and Insight Clinical Presentation of Psychotic Disorders. Slide 4 Motor disturbances include disorders of Appearance mobility, activity and volition. Catatonic – Motor disturbances • Catatonia stupor is a state in which patients are •Stereotypy • Mannerisms immobile, mute, yet conscious. They exhibit – Behavioral problems •Hygiene waxy flexibility, or assumption of bizarre • Social functioning – “Soft signs” postures as most dramatic example. Catatonic excitement is uncontrolled and aimless motor activity. It is important to differentiate from substance-induced movement disorders, such as extrapyramidal symptoms and tardive dyskinesia. Slide 5 Disorders of behavior may involve Appearance deterioration of social functioning-- social • Behavioral Problems • Social functioning withdrawal, self neglect, neglect of • Other – Ex. Neuro soft signs environment (deterioration of housing, etc.), or socially inappropriate behaviors (talking to themselves in
    [Show full text]
  • Neutrophil-Lymphocyte Ratio in Catatonia
    Original article Neutrophil-lymphocyte ratio in catatonia SENGUL KOCAMER SAHIN1 https://orcid.org/0000-0002-5371-3907 CELAL YAşAMALI1 https://orcid.org/0000-0002-2813-2270 MUHAMMET BERKAY ÖZYÜREK2 https://orcid.org/0000-0002-7016-1411 GÜLÇIN ELBOğA1 https://orcid.org/0000-0003-3903-1835 ABDURRAHMAN ALTINDAğ1 https://orcid.org/0000-0001-5531-4419 AHMET ZIYA şAHIN3 https://orcid.org/0000-0001-5853-8709 1 Department of Psychiatry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. 2 Department of Psychiatry, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey. 3 Department of Internal Medicine, Faculty of Medicine, Sanko University, Gaziantep, Turkey. Received: 05/18/2019 – Accepted: 01/14/2020 DOI: 10.1590/0101-60830000000232 Abstract Background: There is growing evidence of subclinical inflammation in mental disorders. Objective: The aim of this study was to investigate frequency of symptoms of catatonia and the newly diagnosed subclinical inflammatory markers which are neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR), monocyte/lymphocyte (MLR) ratios in catatonia patients due to mental disorders. Methods: Patients who were admitted to psychiatry clinic with the diagnosis of catatonia according to DSM 5 in the last two years and equal number of control group were included in this retrospective study. Univariate analysis of covariance controlled for possible confounders was used to compare NLR, PLR, MLR ratios between patients and the control group. Results: A total of 34 catatonia patients and 34 healthy controls were included in the study. Patients’ mean age was 30.88 + 13.4. NLR value was significantly higher in the patient group than control group. There was no significant difference between the patients and control group according to PLR, MLR values.Discussion: The presence of subclinical inflammation in catatonic syndrome due to mental disorders should be considered.
    [Show full text]
  • Catatonia in Depression: Prevalence, Clinical J Neurol Neurosurg Psychiatry: First Published As 10.1136/Jnnp.60.3.326 on 1 March 1996
    32632ournal ofNeurology, Neurosurgery, and Psychiatry 1996;60:326-332 Catatonia in depression: prevalence, clinical J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.3.326 on 1 March 1996. Downloaded from correlates, and validation of a scale Sergio E Starkstein, Gustavo Petracca, Alejandra Teson, Eran Chemerinski, Marcelo Merello, Ricardo Migliorelli, Ramon Leiguarda Abstract mute and immobile, with staring expression, Objectives-To examine the clinical cor- gaze fixed into space, with an apparent com- relates of catatonia in depression, to vali- plete loss of will, no reaction to sensory stim- date a scale for catatonia, and to assess uli, sometimes with the symptom of waxy the validity of the DSM-IV criteria of the flexibility completely developed, as in catatonic features specifier for mood dis- catalepsy, sometimes of a mild degree, but orders. clearly recognisable," and labelled this state Methods-A series of 79 consecutive "vesania katatonica".2 Stressing that catatonia patients with depression and 41 patients was not related to "affective" melancholy with Parkinson's disease without depres- sensu strictu, Wernicke suggested the term sion were examined using the modified "motilitatpsychose", and suggested that this Rogers scale (MRS), the unified disorder may be the result of dysfunction of a Parkinson's disease rating scale "psychomotor path", producing either akine- (UPDRS), and the structured clinical sis, parakinesis, or hyperkinesis.3 Whereas interview for DSM-III-R (SCID). Kahlbaum and Wernicke placed catatonia Results-Sixteen of the 79 depressed within the range of the affective disorders, patients (20%) had catatonia. Depressed Kraepelin4 considered catatonia as a type of patients with catatonia had significantly schizophrenia, and this disorder aroused little higher scores on the MRS than non-cata- interest until recently.
    [Show full text]
  • The Harmony of Illusions the Harmony of Illusions
    THE HARMONY OF ILLUSIONS THE HARMONY OF ILLUSIONS I NVENTING POST-TRAUMATIC STRESS DISORDER Allan Young PRINCETON UNIVERSITY PRESS PRINCETON, NEW JERSEY Copyright 1995 by Princeton University Press Published by Princeton University Press, 41 William Street, Princeton, New Jersey 08540 In the United Kingdom: Princeton University Press, Chichester, West Sussex All Rights Reserved Library of Congress Cataloging-in-Publication Data Young, Allan, 1938– The harmony of illusions : inventing post-traumatic stress disorder / Allan Young. p. cm. Includes bibliographical references and index. ISBN 0-691-03352-8 (cloth : alk. paper) 1. Post-traumatic stress disorder—Philosophy. 2. Social epistemology. I. Title. RC552.P67Y68 1995 616.85′21—dc20 95-16254 This book has been composed in Times Roman Princeton University Press books are printed on acid-free paper and meet the guidelines for permanence and durability of the Committee on Production Guidelines for Book Longevity of the Council on Library Resources Printed in the United States of America by Princeton Academic Press 10987654321 For Roberta Contents Acknowledgments ix Introduction 3 PART I: THE ORIGINS OF TRAUMATIC MEMORY One Making Traumatic Memory 13 Two World War I 43 PART II: THE TRANSFORMATION OF TRAUMATIC MEMORY Three The DSM-III Revolution 89 Four The Architecture of Traumatic Time 118 PART III: POST-TRAUMATIC STRESS DISORDER IN PRACTICE Five The Technology of Diagnosis 145 Six Everyday Life in a Psychiatric Unit 176 Seven Talking about PTSD 224 Eight The Biology of Traumatic Memory 264 Conclusion 287 Notes 291 Works Cited 299 Index 321 Acknowledgments I OWE a debt to colleagues and friends in the Department of Social Studies of Medicine and the Department of Psychiatry at McGill University: I thank Don Bates, Alberto Cambrosio, Margaret Lock, Faith Wallis, George Weisz, and Laurence Kirmayer for their invaluable advice.
    [Show full text]
  • Catatonia in DSM-5
    Schizophrenia Research 150 (2013) 26–30 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Review Catatonia in DSM-5 Rajiv Tandon a,⁎, Stephan Heckers b, Juan Bustillo c, Deanna M. Barch d,e, Wolfgang Gaebel f, Raquel E. Gur g,h, Dolores Malaspina i,j, Michael J. Owen k, Susan Schultz l, Ming Tsuang m,n,o, Jim van Os p,q, William Carpenter r,s a Department of Psychiatry, University of Florida Medical School, Gainesville, FL, USA b Department of Psychiatry, Vanderbilt University, Nashville, TN, USA c Department of Psychiatry, University of New Mexico, Albuquerque, NM, USA d Department of Psychology, Washington University, St. Louis, MO, USA e Department of Psychiatry and Radiology, Washington University, St. Louis, MO, USA f Department of Psychiatry, Duesseldorf, Germany g Department of Psychiatry, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA h Department of Neurology and Radiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA i Department of Psychiatry, New York University, New York, NY, USA j Creedmoor Psychiatric Center, New York State Office of Mental Health, USA k MRC Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom l Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA, USA m Center for Behavioral Genomics, Department of Psychiatry and Institute of Genomic Medicine, University
    [Show full text]
  • Catatonia, NMS, and Serotonin Syndrome
    Catatonia, NMS, and Serotonin Syndrome Christopher M. Celano, MD, FACLP Associate Director, Cardiac Psychiatry Research Program, Massachusetts General Hospital Assistant Professor of Psychiatry, Harvard Medical School October 22, 2020 www.mghcme.org Disclosure: Christopher Celano, MD Sunovion Company Pharmaceuticals Employment Management Independent Contractor Consulting Speaking & Teaching I Board, Panel or Committee Membership D – Relationship is considered directly relevant to the presentation I – Relationship is NOT considered directly relevant to the presentation www.mghcme.org Catatonia: How common is it? • 7.8-9.0% prevalence rate – Highest rates in non-psychiatric (i.e., medical) settings and in patients undergoing ECT. • 1.6-5.5% of all patients seen on psychiatry consultation service – Prevalence higher for older patients • Up to 46% of cases may have etiology that is not primarily psychiatric Grover 2015, Carroll 1994, Jaimes-Albornoz 2013, Fricchione 2008 www.mghcme.org When are you called? • Staff reports the patient is “Playing POSSUM” • Perseveration (speech or behavior) • Oppositionality to all requests • Speech that trails off or is whispereD • Slowed response to questions or commands • Undernourished (reports of decreased PO intake) • Motionless but awake www.mghcme.org Diagnosing Catatonia: DSM-5 DSM-5 requires 3 or more of the following: • Catalepsy • Posturing • Waxy flexibility • Mannerisms • Stupor • Stereotypies • Agitation • Grimacing • Mutism • Echolalia • Negativism • Echopraxia American Psychiatric Association 2013 www.mghcme.org Bush-Francis Rating Scale • Excitement • VerBigeration • Immobility/stupor • Rigidity • ComBativeness • Negativism • Autonomic Abnormality • Waxy flexiBility • Impulsivity • Withdrawal • Mutism • Automatic OBedience • Staring • Mitgehen • Posturing/catalepsy • Gegenhalten • Grimacing • AmBitendency • Echopraxia/echolalia • Grasp Reflex • Stereotypy • Perseveration • Mannerisms Bush 1996 www.mghcme.org Challenges with Diagnosis • Clarifying specific symptoms can be difficult – Rigidity vs.
    [Show full text]
  • Why Do Neurologists Miss Catatonia in Neurology Emergency? a Case
    Clinical Neurology and Neurosurgery 184 (2019) 105375 Contents lists available at ScienceDirect Clinical Neurology and Neurosurgery journal homepage: www.elsevier.com/locate/clineuro Why do neurologists miss catatonia in neurology emergency? A case series T and brief literature review ⁎ Sucharita Ananda, Vimal Kumar Paliwala, , Laxmi S Singha, Ravi Uniyalb a Department of Neurology, SGPGIMS, Raebareli road, Lucknow, UP, India b Department of Neurology, King George Medical University, Lucknow, UP, India ARTICLE INFO ABSTRACT Keywords: Catatonia is a well-described clinical syndrome characterized by features that range from mutism, negativism Catatonia and stupor to agitation, mannerisms and stereotype. Causes of catatonia may range from organic brain disorders Extrapyramidal disorder to psychiatric conditions. Despite a characteristic syndrome, catatonia is grossly under diagnosed. The reason for Parkinsonism missed diagnosis of catatonia in neurology setting is not clear. Poor awareness is an unlikely cause because Major depression catatonia is taught among conditions with deregulated consciousness like vegetative state, locked-in state and Schizophrenia akinetic mutism. We determined the proportion of catatonia patients correctly identified by neurology residents in neurology emergency. We also looked at the alternate diagnosis they received to identify catatonia mimics. Twelve patients (age 22–55 years, 7 females) of catatonia were discharged from a single unit of neurology department from 2007 to 2017. In the emergency department,
    [Show full text]
  • Catatonia in a Patient with Bipolar Disorder Type I
    Published online: 2019-11-13 Letters to the Editor [1] fluid (CSF). The presence of a high CSF: Serum ratio Access this article online of specific IgG antibodies against measles supports the Quick Response Code: diagnosis. Histological findings in sterotactic biopsies or necropsy studies are characterized by a chronic Website: leptomeningeal, perivascular, and parenchymatous www.ruralneuropractice.com chronic inflammatory infiltrate, with neuronal degeneration, gliosis, demyelinization, and astrocyte proliferation. Crowdy type A inclusion bodies are intranuclear or intracytoplasmatic viral particles found both in the neurons and glial cells. Neurofibrillary tangles is another characteristic finding, particularly Catatonia in a patient when the disease has been present for some years.[2,6] with bipolar disorder In adult patients with SSPE, clinical manifestations may be atypical and heterogeneous, with absence of type I myoclonus or EEG periodic complexes, as we can observe in Mahendra et al’s [7] case report; for this reason, a high clinical suspicion index for the diagnosis is required, Sir, and an extensive differential diagnosis should be made Catatonic symptoms can be present in any severe phase to exclude metabolic, demyelinating, genetic, infectious, of bipolar disorder (BD), when the specifier “with and paraneoplastic diseases.[8] In some cases, brain catatonic features” is applied to describe the particular biopsy has been the only method to establish a definitive episode (DSM‑5).[1] There is a wide range of catatonic diagnosis of the disease.[2,6] symptoms; manifestations can vary from negativism, withdrawal, staring, immobility/stupor, mutism, Adrià Arboix posturing, grimacing, stereotypies, and mannerisms to non‑purposeful excitement, undirected combativeness, Department of Neurology, Cerebrovascular Division, unexplained impulsive behavior, echopraxia and Hospital Universitari del Sagrat Cor, Universitat de Barcelona, Catalonia, Spain echolalia.
    [Show full text]
  • State That the Catalepsy Part of the Picture Is in Reality Cataleptoid As Compared to Human Beings
    VOL. 17, 1931 CHEMISTRY: BANCROFT AND RUTZLER, JR. 597- grams, the fish in course of time grew slightly darker as compared with a control animal into which an equal amount of distilled water had been in- jected. This treatment was repeated a number of times and always with the same result. It indicates a slight expansion of the chromatophores as compared with those in the control. On doubling doses the fishes passed into a condition of mild coma and several of them sooner or later died. Similar tests on the common spotted frog though continued over a con- siderable period never brought forth any observable change in the color of the skin though the animals showed pronounced respiratory disturbances. As the concentration of the drug used in both these sets of tests, one part in a thousand, is far removed from that at which it affects smooth muscle, namely, a few parts in a hundred million, I conclude that, as far as these tests go, acetyl choline is not to be regarded as an important means in influencing chromatophores. R. Hunt, "Vasodilator Reactions. I," Amer. J. Physiol., 45, 197-230 (1918). RE VERSIBLE COAGULA TION IN LIVING TISSUE. VIII* BY WILDER D. BANCROFT AND JOHN E. RUTZLER, JR.** BAKER CHEMICAL LABORATORY, CORNELL UNIVERSITY Communicated September 30, 1931 Within the last few years it has become quite the fashion to study the cataleptoid and catatonic conditions brought about in animals by the use of the alkaloid bulbocapnine. These studies have had as their object the hope that the insight gained by studying the reactions of animals to bulbocapnine would throw light upon the perplexing problem of the human stupor syndrome.
    [Show full text]
  • The Treatment-Resistant Catatonia Patient Ahmed Aboraya, MD, Drph, Paramjit Chumber, MD, and Bahar Altaha, MD
    Cases That Test Your Skills The treatment-resistant catatonia patient Ahmed Aboraya, MD, DrPH, Paramjit Chumber, MD, and Bahar Altaha, MD How would you Ms. R develops severe catatonia after being hospitalized handle this case? with agitation, delusions, and hallucinations. A Visit CurrentPsychiatry.com to input your answers benzodiazepine does not help. How would you treat her? and see how your colleagues responded CASE Worsening psychosis tor Ms. R and administer haloperidol as needed, Ms. R, age 21, is admitted to our psychiatric 10 mg total. Eight days after admission, she de- facility while experiencing paranoid delusions velops severe catatonia. On the catatonia scale ® and auditory hallucinations.Dowden Upon admission, Health of the MediaSCIP, Ms. R scores the maximum on mea- she is agitated and her mood is labile. sures of immobility, catalepsy/waxy fl exibility, CopyrightMs. R has 4 previousFor briefpersonal psychiatric admis- use andonly mutism (Table). sions and was diagnosed with schizoaff ective disorder, bipolar type and moderate mental How would you treat Ms. R’s catatonia? retardation. Her family history is positive for a) restart ziprasidone and lithium psychiatric illness, as her mother was diag- b) refer her for medical evaluation to rule nosed with schizophrenia. Prior to admission, out organic causes of catatonia Ms. R was taking ziprasidone, 160 mg/d, and c) prescribe a benzodiazepine d) try a diff erent antipsychotic lithium, 450 mg/d, for 11 months. Both were discontinued during the fi rst week of admis- sion because Ms. R was not responding. The authors’ observations During this admission, the treating psy- DSM-IV-TR recognizes catatonia as a schizo- chiatrist assesses Ms.
    [Show full text]
  • Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?
    brain sciences Review Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model? Roberto Keller 1 , Tatiana Costa 1, Daniele Imperiale 2, Annamaria Bianco 3 , Elisa Rondini 3, Angela Hassiotis 4 and Marco O. Bertelli 3,* 1 Adult Autism Centre, Mental Health Department, ASL Città di Torino, 10138 Turin, Italy; [email protected] (R.K.); [email protected] (T.C.) 2 Neurology Unit, Maria Vittoria Hospital, ASL Città di Torino, 10144 Turin, Italy; [email protected] 3 CREA (Research and Clinical Centre), San Sebastiano Foundation, Misericordia di Firenze, 50142 Florence, Italy; [email protected] (A.B.); [email protected] (E.R.) 4 Division of Psychiatry, University College London, London W1T 7NF, UK; [email protected] * Correspondence: [email protected]; Tel.: +39-055-708880 Abstract: Background: Stereotypic behaviour can be defined as a clear behavioural pattern where a specific function or target cannot be identified, although it delays on time. Nonetheless, repetitive and stereotypical behaviours play a key role in both animal and human behaviour. Similar behaviours are observed across species, in typical human developmental phases, and in some neuropsychiatric conditions, such as Autism Spectrum Disorder (ASD) and Intellectual Disability. This evidence led to the spread of animal models of repetitive behaviours to better understand the neurobiological mechanisms underlying these dysfunctional behaviours and to gain better insight into their role and Citation: Keller, R.; Costa, T.; origin within ASD and other disorders. This, in turn, could lead to new treatments of those disorders Imperiale, D.; Bianco, A.; Rondini, E.; in humans. Method: This paper maps the literature on repetitive behaviours in animal models of ASD, Hassiotis, A.; Bertelli, M.O.
    [Show full text]
  • Ect for Catatonia in Autism Spectrum Disorders
    ECT FOR CATATONIA IN AUTISM SPECTRUM DISORDERS Dirk Dhossche MD PhD Professor of Psychiatry University of Mississippi Medical Center [email protected] NACT NYKÖPING 2016 Disclosures NONE Pediatric disorders associated with catatonia Developmental Disorders • Autism Spectrum Disorders (ASD) • Childhood Disintegrative Disorder • ID including Down Syndrome and Prader-Willi Syndrome • Tic Disorders, Tourette Syndrome Pediatric disorders associated with catatonia Miscellaneous Conditions • Anti-NMDARe (malignant catatonia + an antibody) • PANDAS (catatonia + an antibody) • Aseptic encephalitis (type EL) (autoimmune catatonia) • Kleine Levin Syndrome (episodic adolescent catatonia) • Psychogenic catalepsy (~ post-traumatic catatonia) • Anaclitic depression (Spitz) (~ anaclitic catatonia) • Pervasive Refusal Syndrome (exclusively European) • Nodding Syndrome (exclusively in Uganda & South Sudan) Prevalence of pediatric catatonia: studies since 1992 N Sample population % cat Green (1992) 38 Prosp, Child Schizo 32 Moise (1996) 13 Retrospective, ECT 46 Wing (2000) 506 Prospective, Autism 17 Thakur (2003) 198 Prospective, clinics 18 Billstedt (2005) 120 Prospective, Autism 12 Ohta (2006) 69 Prospective, Autism 12 Hutton (2008) 135 Prospective, Autism 5 Consoli (2009) 199 Meta-analysis, ECT 6 Ghaziuddin (2012) 101 Retro, At-risk inpts 18 Goetz (2014) 69 Retro, Ado 1st-Break 36 Mantra of the catatonia scholar Catatonia is a poorly recognized syndrome (not a symptom!) & emergency that is eminently treatable with benzo’s and ECT Modern Catatonia Research TREATMENT ISSUES 1 case with malignant catatonia 2 cases with catatonia and ASD EVALUATION, DIAGNOSIS, TREATMENT OF PEDIATRIC CATATONIA POSSIBLE CATATONIA WORK-UP CRITERIA CATATONIA LZP Test IMPROVED NOT IMPROVED M-LZP BILATERAL ECT M-ECT 10-year-old boy from California with high-func:oning ASD • Acute onset OCD, 2 days aAer he became extremely upset aAer his best friend spit on his thermos during school, October 2012.
    [Show full text]